Valeritas up 42% premarket as managed care providers pick up V-Go
Thinly traded nano cap Valeritas Holdings (NASDAQ:VLRX) is up 42% premarket on robust volume in reaction to its disclosure that Cigna, Humana and CVS Health have added its V-Go Wearable Insulin Delivery device to their managed care formularies.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.